Table 2. Adverse birth outcomes in pre-Omicron era vs Omicron era.
| Adverse birth outcome | Pre-Omicron era N = 11,483 |
Omicron era N = 8,814 |
||||||
|---|---|---|---|---|---|---|---|---|
| HIV+ COVID- (N = 2,277) |
HIV- COVID+ (N = 395) |
HIV+ COVID+ (N = 144) |
HIV- COVID- (N = 8,667) |
HIV+ COVID- (N = 1,756) |
HIV-COVID+ (N = 293) |
HIV+ COVID+ (N = 77) |
HIV-COVID- (N = 6,688) |
|
| Stillbirth | 69 (3.0%) | 24 (6.1%) | 6 (4.2%) | 228 (2.6%) | 52 (3%) | 7 (2.4%) | 0 | 146 (1.7%) |
| Preterm delivery | 326 (14.7%) | 76 (19.8%) | 36 (25.5%) | 1105 (13.1%) | 282 (16.5%) | 42 (14.6%) | 13 (17.1%) | 950 (14.5%) |
| Very preterm delivery | 65 (2.9%) | 14 (3.7%) | 9 (6.4%) | 256 (3.0%) | 68 (4%) | 8 (2.8%) | 4 (5.3%) | 224 (3.4%) |
| Small for gestational age (SGA) | 405 (18.3%) | 51 (13.5%) | 31 (22.0%) | 1211 (14.4%) | 319 (18.8%) | 40 (14%) | 11 (14.7%) | 1036 (15.9%) |
| Very SGA | 160 (7.2%) | 17 (4.5%) | 12 (8.5%) | 449 (5.3%) | 130 (7.7%) | 19 (6.6%) | 6 (8%) | 366 (5.6%) |
| Neonatal death | 33 (1.5%) | 6 (1.6%) | 4 (2.9%) | 105 (1.3%) | 34 (2%) | 6 (2.1%) | 1 (1.3%) | 90 (1.4%) |